scientific paper on abortion rate for injected women in first and second trimester (86%)

Spontaneous Abortions and Policies on COVID-19 mRNA Vaccine Use During Pregnancy

Additionally, the product’s manufacturer, Pfizer, contradicts these assurances, stating:

“available data on Comirnaty administered to pregnant women are insufficient to inform vaccineassociated risks in pregnancy”, and “it is not known whether Comirnaty is excreted in human milk” as “data are not available to assess the effects of Comirnaty on the breastfed infant” (page 14).[39]

Due to the nature of the mRNA vaccine roll-out, healthcare providers need to report any issues in pregnancy to further determine the safety of this product. Caution should be exercised in the

administration of vaccines in pregnancy, as indicated by the possible association between the exposure to influenza vaccines containing H1N1pdm09 (2010–11 and 2011–12) and spontaneous abortion.[40] Considering the evidence presented here, we suggest the immediate withdrawal of mRNA vaccine use in pregnancy (Category X)[41] and those breastfeeding, alongside the withdrawal of mRNA vaccines to children or those of child-bearing age in the general population, until more convincing data relating to the safety and long-term impacts on fertility, pregnancy and reproduction are established in these groups